BioCentury
ARTICLE | Clinical News

Faropenem medoxomil regulatory update

October 30, 2006 8:00 AM UTC

Replidyne Inc. (RDYN), Louisville, Colo. Forest Laboratories Inc. (FRX), New York, N.Y. Product: Faropenem medoxomil Business: Infectious RDYN received a not approvable letter from FDA for faropenem,...